I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we are, a quarter of a century later, almost to the exact day, and it’s happening again.

Agnes Rey-Giraud net worth and biography

Agnes Rey-Giraud Biography and Net Worth

Director of GoodRx

Agnes Rey-Giraud has served as a member of our board of directors since June 2016. Ms. Rey-Giraud is the Founder, Chairman and Chief Executive Officer of Acera Surgical Inc., a bioscience company, where she has served since its founding in January 2013. Ms. Rey-Giraud previously served as an Executive Vice President and the President of International Operations at Express Scripts, a pharmacy benefit management organization, from May 1999 to May 2011. Ms. Rey-Giraud will serve on the board of directors of UpHealth, Inc. upon the closing of GigCapital2, Inc.'s merger with UpHealth Holdings, Inc. Ms. ReyGiraud also serves on the board of directors for several private companies. Ms. Rey-Giraud holds a B.S. and M.S. in Mechanical Engineering from Ecole Nationale d’Ingenieurs de Saint Etienne (ENISE), France, a MMa in Operations Management from Ecole de Management de Lyon (EM Lyon), France and an M.B.A. from the University of Chicago.

How do I contact Agnes Rey-Giraud?: The corporate mailing address for Ms. Rey-Giraud and other GoodRx executives is 233 WILSHIRE BLVD. SUITE 990, SANTA MONICA CA, 90401. GoodRx can also be reached via phone at 855-268-2822 and via email at [email protected]. Learn More on Agnes Rey-Giraud's contact information.
Has Agnes Rey-Giraud been buying or selling shares of GoodRx?: Agnes Rey-Giraud has not been actively trading shares of GoodRx in the last ninety days. Most recently, Agnes Rey-Giraud sold 5,909 shares of the business's stock in a transaction on Thursday, September 16th. The shares were sold at an average price of $45.01, for a transaction totalling $265,964.09. Learn More on Agnes Rey-Giraud's trading history.
Who are GoodRx's active insiders?: GoodRx's insider roster includes Babak Azad (Insider), Trevor Bezdek (Co-founder & Chairman), Douglas Hirsch (CEO), Bansi Nagji (Insider), Agnes Rey-Giraud (Director), Andrew Slutsky (Insider), Karsten Voermann (CFO), and Scott Wagner (Insider). Learn More on GoodRx's active insiders.
Are insiders buying or selling shares of GoodRx?: During the last twelve months, GoodRx insiders bought shares 2 times. They purchased a total of 25,809 shares worth more than $149,657.52. During the last twelve months, insiders at the sold shares 1 times. They sold a total of 10,677 shares worth more than $83,921.22. The most recent insider tranaction occured on September, 3rd when Major Shareholder Equity Vii L.P. Spectrum sold 10,677 shares worth more than $83,921.22. Insiders at GoodRx own 4.2% of the company. Learn More about insider trades at GoodRx.
Information on this page was last updated on 9/3/2024.

Agnes Rey-Giraud Insider Trading History at GoodRx

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction
9/16/2021	Sell	5,909	$45.01	$265,964.09
9/14/2021	Sell	14,454	$45.00	$650,430.00
4/1/2021	Sell	25,000	$40.01	$1,000,250.00
3/22/2021	Sell	25,000	$36.38	$909,500.00

Agnes Rey-Giraud Buying and Selling Activity at GoodRx

GoodRx Company Overview

GoodRx Holdings, Inc., together with its subsidiaries, offers information and tools that enable consumers to compare prices and save on their prescription drug purchases in the United States. The company operates a price comparison platform that provides consumers with curated, geographically relevant prescription pricing, and access to negotiated prices. It also offers other healthcare products and services, including subscriptions, and pharma manufacturer solutions, as well as telehealth services through the GoodRx Care platform. It serves pharmacy benefit managers who manage formularies and prescription transactions, including establishing pricing between consumers and pharmacies. The company was founded in 2011 and is headquartered in Santa Monica, California.

Today's Range

Now: $4.90

$4.24

$4.91

50 Day Range

MA: $6.22

$4.15

$7.68

2 Week Range

Now: $4.90

$4.09

$9.26

Volume

2,976,553 shs

Average Volume

1,452,888 shs

Market Capitalization

$1.87 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.39

I was wrong. Dead wrong.

From Porter & Company | Ad